Company Profile
Updated: 17-SEP-09StemCells Inc.
Public Company, Headquarters Location
3155 Porter Dr., Palo Alto, CA 94304-1213, United States
(650)475-3100, (650)475-3101 fax, http://www.stemcellsinc.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Manufactures cell based therapeutics.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
CRWENews Highlights: STEM, SNY.
M2 Presswire; 12/11/2009; 1322 words; ...announce a stock highlight on StemCells, Inc. (NASDAQ: STEM), Sanofi...EURONEXT: SAN and NYSE: SNY StemCells, Inc. (NASDAQ: STEM) announced...practice of medicine. About StemCells, Inc. StemCells, Inc. is focused...
StemCells, Inc. CEO Martin McGlynn Featured On BioBusiness.TV's "Stem Cell Review" Series.
Biotech Week; 12/9/2009; 682 words; StemCells, Inc. (NASDAQ: STEM) announced that its...authorities in the field (see also StemCells, Inc.). Mr. McGlynn's interview is...Stem Cells, Therapy, Treatment, StemCells Inc. This article was prepared by Biotech...
Research and Markets Offers Report: Global Stem Cell and Advanced Technologies Market
Wireless News; 12/8/2009; 793 words; ...Neuralstem Biopharmaceuticals, Ltd. - Opexa Therapeutics - Osiris Therapeutics, Inc - Plureon Corp - Pluristem Therapeutics - Reneuron, Inc - Stemcells, Inc - Stemlifeline - T2Cure Gmbh - Theravitae - Thermo Fisher Scientific Inc - Thermogenesis...
Research and Markets Adds Report: Global Stem Cell and Advanced Technologies Market
Wireless News; 12/7/2009; 792 words; ...Neuralstem Biopharmaceuticals, Ltd. - Opexa Therapeutics - Osiris Therapeutics, Inc - Plureon Corp - Pluristem Therapeutics - Reneuron, Inc - Stemcells, Inc - Stemlifeline - T2Cure Gmbh - Theravitae - Thermo Fisher Scientific Inc - Thermogenesis...
StemCells, Inc. Initiates Landmark Trial Targeting "Communication Highway" of the Brain.
Clinical Trials Week; 12/7/2009; 1738 words; StemCells, Inc. (NASDAQ: STEM) announced that...neurology and neurosurgery (see also StemCells, Inc.). PMD results from a defective...President and Head of the CNS Program at StemCells, Inc. "We are investigating a cell therapy...
Recent News Articles
- StemCells, Inc. CEO Martin McGlynn Featured On BioBusiness.TV's "Stem Cell Review" Series.
Biotech Week - December 09, 2009 - StemCells, Inc. Welcomes Approval of First Embryonic Stem Cell Lines Under New NIH Guidelines.
Business Wire - December 03, 2009 - StemCells, Inc. CEO Martin McGlynn Featured On BioBusiness.TV's "Stem Cell Review" Series.
Business Wire - November 23, 2009 - StemCells, Inc. Initiates Landmark Trial Targeting "Communication Highway" of the Brain.
Business Wire - November 23, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning